LPTX
Price
$0.34
Change
-$0.00 (-0.00%)
Updated
Jul 21 closing price
Capitalization
14.05M
MNKD
Price
$3.82
Change
+$0.06 (+1.60%)
Updated
Jul 21 closing price
Capitalization
1.16B
15 days until earnings call
Interact to see
Advertisement

LPTX vs MNKD

Header iconLPTX vs MNKD Comparison
Open Charts LPTX vs MNKDBanner chart's image
Leap Therapeutics
Price$0.34
Change-$0.00 (-0.00%)
Volume$393.45K
Capitalization14.05M
MannKind
Price$3.82
Change+$0.06 (+1.60%)
Volume$2.62M
Capitalization1.16B
LPTX vs MNKD Comparison Chart in %
Loading...
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LPTX vs. MNKD commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPTX is a StrongBuy and MNKD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (LPTX: $0.34 vs. MNKD: $3.82)
Brand notoriety: LPTX and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPTX: 21% vs. MNKD: 99%
Market capitalization -- LPTX: $14.05M vs. MNKD: $1.16B
LPTX [@Biotechnology] is valued at $14.05M. MNKD’s [@Biotechnology] market capitalization is $1.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNKD’s FA Score shows that 0 FA rating(s) are green whileLPTX’s FA Score has 0 green FA rating(s).

  • MNKD’s FA Score: 0 green, 5 red.
  • LPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both MNKD and LPTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPTX’s TA Score shows that 6 TA indicator(s) are bullish while MNKD’s TA Score has 5 bullish TA indicator(s).

  • LPTX’s TA Score: 6 bullish, 4 bearish.
  • MNKD’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both LPTX and MNKD are a good buy in the short-term.

Price Growth

LPTX (@Biotechnology) experienced а +2.70% price change this week, while MNKD (@Biotechnology) price change was -5.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.37%. For the same industry, the average monthly price growth was +15.66%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

LPTX is expected to report earnings on May 13, 2025.

MNKD is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNKD($1.16B) has a higher market cap than LPTX($14M). MNKD YTD gains are higher at: -40.591 vs. LPTX (-88.209). MNKD has higher annual earnings (EBITDA): 82.6M vs. LPTX (-71.67M). MNKD has more cash in the bank: 182M vs. LPTX (32.7M). LPTX has less debt than MNKD: LPTX (154K) vs MNKD (47.2M). MNKD has higher revenues than LPTX: MNKD (298M) vs LPTX (0).
LPTXMNKDLPTX / MNKD
Capitalization14M1.16B1%
EBITDA-71.67M82.6M-87%
Gain YTD-88.209-40.591217%
P/E RatioN/A38.20-
Revenue0298M-
Total Cash32.7M182M18%
Total Debt154K47.2M0%
FUNDAMENTALS RATINGS
MNKD vs LPTX: Fundamental Ratings
MNKD
LPTX
OUTLOOK RATING
1..100
541
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
37
Fair valued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
8693
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LPTX's Valuation (37) in the Biotechnology industry is in the same range as MNKD (48). This means that LPTX’s stock grew similarly to MNKD’s over the last 12 months.

MNKD's Profit vs Risk Rating (67) in the Biotechnology industry is somewhat better than the same rating for LPTX (100). This means that MNKD’s stock grew somewhat faster than LPTX’s over the last 12 months.

LPTX's SMR Rating (99) in the Biotechnology industry is in the same range as MNKD (100). This means that LPTX’s stock grew similarly to MNKD’s over the last 12 months.

MNKD's Price Growth Rating (86) in the Biotechnology industry is in the same range as LPTX (93). This means that MNKD’s stock grew similarly to LPTX’s over the last 12 months.

MNKD's P/E Growth Rating (99) in the Biotechnology industry is in the same range as LPTX (100). This means that MNKD’s stock grew similarly to LPTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LPTXMNKD
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRD14.801.05
+7.64%
DRDGOLD Ltd
CSTE1.720.04
+2.38%
Caesarstone Ltd
UAA6.980.12
+1.75%
Under Armour
BAX27.37-0.40
-1.44%
Baxter International
PWM0.39-0.02
-4.25%
Prestige Wealth

LPTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LPTX has been loosely correlated with SABS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LPTX jumps, then SABS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPTX
1D Price
Change %
LPTX100%
-1.45%
SABS - LPTX
48%
Loosely correlated
+5.06%
INKT - LPTX
42%
Loosely correlated
-2.51%
AXON - LPTX
40%
Loosely correlated
-0.60%
TECX - LPTX
38%
Loosely correlated
+0.05%
AMRN - LPTX
35%
Loosely correlated
-1.71%
More

MNKD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with VCYT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
+1.60%
VCYT - MNKD
44%
Loosely correlated
-2.04%
LXRX - MNKD
42%
Loosely correlated
N/A
INSM - MNKD
40%
Loosely correlated
+0.22%
UTHR - MNKD
38%
Loosely correlated
+0.38%
CCCC - MNKD
38%
Loosely correlated
-2.16%
More